What is it about?
This article illustrates that two types of cells in the prostate gland—normal and cancerous—respond very differently to inhibitors of the enzyme 5-alpha-reductase. Changes in the functioning of this enzyme are significant in conditions such as benign prostatic hyperplasia and prostate cancer.
Featured Image
Photo by julien Tromeur on Unsplash
Why is it important?
This article is significant because it shows how normal and cancerous prostate cells respond differently to dutasteride, finasteride, and a new derivative of dehydroepiandrosterone.
Perspectives
This work emphasizes the necessity for scientists to report their experiments by comparing diseased cells with normal ones, as diseased cells can respond very differently to treatments.
Dr Marisa Cabeza
Universidad Autónoma Metropolitana-Xochimilco
Read the Original
This page is a summary of: Impact of a Novel Dehydroepiandrosterone Derivative on the Metabolism of RWPE-1 and LNCaP Cell Lines, Oriental Journal Of Chemistry, June 2026, Oriental Scientific Publishing Company,
DOI: 10.13005/ojc/420336.
You can read the full text:
Contributors
The following have contributed to this page
